Polaryx Therapeutics, Inc. - 10-Q Filing
Polaryx Therapeutics reports Q3 2026 cash balance of $8.4M with total assets of $8.6M.
Tickers: $PLYX
More Regulatory news
- FACT II Acquisition Corp. - 10-Q Filing
- Marblegate Capital Corp - 10-Q Filing
- Greenland Mines Ltd - 8-K Filing
- InspireMD, Inc. - 8-K Filing
- InspireMD, Inc. - 8-K Filing
- Pinnacle Acquisition Corp - 10-Q Filing
- SUTRO BIOPHARMA, INC. - 8-K Filing
- Aeluma, Inc. - 8-K Filing
- ASTEC INDUSTRIES INC - 8-K Filing
- Live Oak Bancshares, Inc. - 8-K Filing